Early studies demonstrate that this peptide – a dual stimulator of GLP-1 and GIP receptors – presents a considerable breakthrough in metabolic management therapies. Unlike existing treatments , this dual-action compound shows to influence food intake and energy burn via separate mechanisms . Although additional analysis is required , early res